Plain-English translation of NCT06980636 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether , a traditional Chinese medicine, can help reduce the severe fatigue that some people experience after COVID-19 infection. The trial will compare this medication to a placebo (a look-alike substance with no active ingredients) to see if it actually works. The study will also look at whether the treatment helps with anxiety, depression, sleep quality, and overall quality of life.
Long COVID fatigue can be extremely debilitating and there are currently limited treatment options available. This trial exists to see if this medication might offer a safe and effective way to help people regain their energy and improve their daily functioning.
You likely qualify if…
You likely don't qualify if…
You would take either the medication or a placebo by mouth three times a day for 8 weeks. You would visit the clinic twice during the treatment (once at 4 weeks and once at 8 weeks) for check-ups and tests, plus receive two brief phone calls—one after 15 days and another 30 days after treatment ends. Throughout the study, your fatigue levels, anxiety, depression, sleep, and overall quality of life will be measured to see if the treatment is helping.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
China